Immunovant holds annual stockholder meeting with 96% shares represented

PUBT · 1d ago
Immunovant holds annual stockholder meeting with 96% shares represented
  • Immunovant held its annual shareholder meeting on Sept. 2, 2026.
  • Shareholders backed the selection of Ernst & Young as independent registered public accounting firm for fiscal 2027.
  • Three directors were chosen to serve on the board through the 2027 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001764013-26-000106), on September 03, 2026, and is solely responsible for the information contained therein.